Optimizing Lentiviral Vector Production: Insights Into PiggyBac Transposase and Concatemeric Array Strategies

Area of Science:

• Gene Therapy
• Molecular Biology
• Biotechnology

Background:

• Lentiviral vectors (LVVs) are crucial for gene and cell therapy, enabling transduction of various cell types.
• Conventional LVV production via transient transfection is inefficient and difficult to scale.
• Stable producer cell lines are needed, but historical methods like concatemeric-array integration have drawbacks.

Purpose of the Study:

• To evaluate a transposase-mediated integration strategy as an alternative to concatemeric-array integration for LVV producer cell line generation.
• To compare the efficiency, scalability, and stability of transposase-based versus concatemeric-array integration methods.

Main Methods:

• Generation of stable LVV producer cell lines using transposase-mediated integration.
• Comparison of transposase-mediated integration with the historical concatemeric-array integration method.
• Assessment of cell recovery, genetic stability, cell growth, and LVV production titers.

Main Results:

• Transposase-based integration required less DNA and resulted in faster recovery post-selection with minimal viability loss.
• Both methods showed comparable cell growth stability during LVV production.
• Transposase-mediated pools demonstrated more consistent performance and reliability for large-scale applications, despite concatemeric pools achieving higher maximum titers.

Conclusions:

• Transposase-based integration is a robust and scalable alternative for generating stable LVV producer cell lines.
• This method offers significant advantages over concatemeric-array integration, including reduced complexity and improved consistency.
• The findings have the potential to streamline LVV manufacturing processes for advanced gene and cell therapies.